Albumin-bound nanoparticle (nab) paclitaxel exhibits enhanced paclitaxel tissue distribution and tumor penetration

被引:0
作者
Nianhang Chen
Carrie Brachmann
Xiping Liu
Daniel W. Pierce
Joyoti Dey
William S. Kerwin
Yan Li
Simon Zhou
Shihe Hou
Michael Carleton
Richard A. Klinghoffer
Maria Palmisano
Rajesh Chopra
机构
[1] Celgene Corporation,
[2] Celgene Corporation,undefined
[3] Presage Biosciences,undefined
来源
Cancer Chemotherapy and Pharmacology | 2015年 / 76卷
关键词
Taxane; Nanoparticle; Albumin; -paclitaxel; Cremophor EL;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:699 / 712
页数:13
相关论文
共 318 条
[1]  
Schiff PB(1980)Taxol stabilizes microtubules in mouse fibroblast cells Proc Natl Acad Sci USA 77 1561-1565
[2]  
Horwitz SB(1994)Paclitaxel (Taxol) and docetaxel (Taxotere): not simply two of a kind Ann Oncol 5 495-505
[3]  
Verweij J(1990)Hypersensitivity reactions from taxol J Clin Oncol 8 1263-1268
[4]  
Clavel M(2009)Cremophor EL-containing paclitaxel-induced anaphylaxis: a call to action Community Oncol 6 132-134
[5]  
Chevalier B(2006)Peripheral neuropathy: a persisting challenge in paclitaxel-based regimes Eur J Cancer 42 24-30
[6]  
Weiss RB(2001)Pharmacokinetic modeling of paclitaxel encapsulation in Cremophor EL micelles Cancer Chemother Pharmacol 47 309-318
[7]  
Donehower RC(2006)Increased antitumor activity, intratumor paclitaxel concentrations, and endothelial cell transport of cremophor-free, albumin-bound paclitaxel, ABI-007, compared with cremophor-based paclitaxel Clin Cancer Res 12 1317-1324
[8]  
Wiernik PH(2008)Improved effectiveness of nanoparticle albumin-bound (nab) paclitaxel versus polysorbate-based docetaxel in multiple xenografts as a function of HER2 and SPARC status Anticancer Drugs 19 899-909
[9]  
Ohnuma T(2005)Phase III trial of nanoparticle albumin-bound paclitaxel compared with polyethylated castor oil-based paclitaxel in women with breast cancer J Clin Oncol 23 7794-7803
[10]  
Gralla RJ(2012)Weekly nab-paclitaxel in combination with carboplatin versus solvent-based paclitaxel plus carboplatin as first-line therapy in patients with advanced non-small-cell lung cancer: final results of a phase III trial J Clin Oncol 30 2055-2062